NumerixS Investment Technologies’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-22,200	Closed	-$116K	–	1137
2017 Q3	$116K	Sell	22,200 -13,000	-37%	-$67.9K	0.03%	702
2017 Q2	$196K	Buy	+35,200	New	+$196K	0.03%	644